ScientifyResearch logo
Grant Alerts

GRANT Guide

Home » Grants » Challenge Programme 2023 – RNA- and Oligonucleotide-based Therapeutics (Denmark)

This opportunity is currently closed.

Sign up for Content Alerts to stay informed when this or related funding opportunities are posted.

Challenge Programme 2023 – RNA- and Oligonucleotide-based Therapeutics (Denmark)

The Challenge Programme 2023 – RNA- and Oligonucleotide-based Therapeutics from the Novo Nordisk Fonden (NNF) supports research teams working on basic science that facilitate development of RNA and oligonucleotide-based therapeutics within common clinical conditions, primarily cardiometabolic diseases, efficiently targeting the relevant tissue, cell types and subcellular localisation. The project lead must be at least 75% affiliated with a Danish university, research institution or other non-profit organization. The programme provides between 30-60 million DKK over 6 years. Applications close on October 26, 2022.

Intended for: Clinical researchers|Early-career principal investigators|Mid-career researchers|Senior researchers

Discipline: Cardiology|Endocrinology|Medicine

Challenge: SDG3 - Good Health and Well-being

Sign in with your free account to see important eligibility criteria, including research location, citizenship, legal working rights and deadline/s.

Sign-in for link to funder’s page
Create Grant Alerts

…share with your friends

Related Posts

Search all grants
Logo2

more time for research

About
Us

Funding
Blog & Events

Special
Research Funding

Funding by
Career Stage

Funding by
Subject

Funding by
Location

COPYRIGHT © 2023 SCIENTIFYRESEARCH
Logo2

more time for research

COPYRIGHT © 2023 SCIENTIFYRESEARCH

Sign-up for the
scientifyRESEARCH
monthly research
funding newsletter

You can unsubscribe at any time.